Literature DB >> 9435056

Production of active chimeric pediocin AcH in Escherichia coli in the absence of processing and secretion genes from the Pediococcus pap operon.

K W Miller1, R Schamber, Y Chen, B Ray.   

Abstract

Minimum requirements have been determined for synthesis and secretion of the Pediococcus antimicrobial peptide, pediocin AcH, in Escherichia coli. The functional mature domain of pediocin AcH (Lys+1 to Cys+44) is targeted into the E. coli sec machinery and secreted to the periplasm in active form when fused in frame to the COOH terminus of the secretory protein maltose-binding protein (MBP). The PapC-PapD specialized secretion machinery is not required for secretion of the MBP-pediocin AcH chimeric protein, indicating that in Pediococcus, PapC and PapD probably are required for recognition and processing of the leader peptide rather than for translocation of the mature pediocin AcH domain across the cytoplasmic membrane. The chimeric protein displays bactericidal activity, suggesting that the NH2 terminus of pediocin AcH does not span the phospholipid bilayer in the membrane-interactive form of the molecule. However, the conserved Lys(+1)-Tyr-Tyr-Gly-Asn-Gly-Val(+7)-sequence at the NH2 terminus is important because deletion of this sequence abolishes activity. The secreted chimeric protein is released into the culture medium when expressed in a periplasmic leaky E. coli host. The MBP fusion-periplasmic leaky expression system should be generally advantageous for production and screening of the activity of bioactive peptides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9435056      PMCID: PMC124665     

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  44 in total

1.  Development of a beta-galactosidase alpha-complementation system for molecular cloning in Bacillus subtilis.

Authors:  P Haima; D van Sinderen; H Schotting; S Bron; G Venema
Journal:  Gene       Date:  1990-01-31       Impact factor: 3.688

2.  New biologically active hybrid bacteriocins constructed by combining regions from various pediocin-like bacteriocins: the C-terminal region is important for determining specificity.

Authors:  G Fimland; O R Blingsmo; K Sletten; G Jung; I F Nes; J Nissen-Meyer
Journal:  Appl Environ Microbiol       Date:  1996-09       Impact factor: 4.792

3.  Overproduction of transposon Tn10-encoded tetracycline resistance protein results in cell death and loss of membrane potential.

Authors:  B Eckert; C F Beck
Journal:  J Bacteriol       Date:  1989-06       Impact factor: 3.490

4.  Characterization of degP, a gene required for proteolysis in the cell envelope and essential for growth of Escherichia coli at high temperature.

Authors:  K L Strauch; K Johnson; J Beckwith
Journal:  J Bacteriol       Date:  1989-05       Impact factor: 3.490

5.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

Review 6.  Mechanism of lantibiotic-induced pore-formation.

Authors:  G N Moll; G C Roberts; W N Konings; A J Driessen
Journal:  Antonie Van Leeuwenhoek       Date:  1996-02       Impact factor: 2.271

7.  Signal sequences. The limits of variation.

Authors:  G von Heijne
Journal:  J Mol Biol       Date:  1985-07-05       Impact factor: 5.469

8.  The antistaphylococcal effect of nisin in a suitable vehicle: a potential therapy for atopic dermatitis in man.

Authors:  C Valenta; A Bernkop-Schnürch; H P Rigler
Journal:  J Pharm Pharmacol       Date:  1996-09       Impact factor: 3.765

9.  Biosynthesis of lantibiotic nisin. Posttranslational modification of its prepeptide occurs at a multimeric membrane-associated lanthionine synthetase complex.

Authors:  K Siegers; S Heinzmann; K D Entian
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

10.  Functional analysis of the pediocin operon of Pediococcus acidilactici PAC1.0: PedB is the immunity protein and PedD is the precursor processing enzyme.

Authors:  K Venema; J Kok; J D Marugg; M Y Toonen; A M Ledeboer; G Venema; M L Chikindas
Journal:  Mol Microbiol       Date:  1995-08       Impact factor: 3.501

View more
  15 in total

1.  Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli.

Authors:  Quande Wei; Young Soo Kim; Jeong Hyun Seo; Woong Sik Jang; In Hee Lee; Hyung Joon Cha
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

Review 2.  The continuing story of class IIa bacteriocins.

Authors:  Djamel Drider; Gunnar Fimland; Yann Héchard; Lynn M McMullen; Hervé Prévost
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

3.  Construction of plasmid vector for expression of bacteriocin N15-encoding gene and effect of engineered bacteria on Enterococcus faecalis.

Authors:  Monthon Lertcanawanichakul
Journal:  Curr Microbiol       Date:  2007-01-02       Impact factor: 2.188

4.  Determination of essential and variable residues in pediocin PA-1 by NNK scanning.

Authors:  Tatsuya Tominaga; Yoshinori Hatakeyama
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

5.  The bactericidal activity of pediocin PA-1 is specifically inhibited by a 15-mer fragment that spans the bacteriocin from the center toward the C terminus.

Authors:  G Fimland; R Jack; G Jung; I F Nes; J Nissen-Meyer
Journal:  Appl Environ Microbiol       Date:  1998-12       Impact factor: 4.792

6.  Isolation and characterization of pediocin AcH chimeric protein mutants with altered bactericidal activity.

Authors:  K W Miller; R Schamber; O Osmanagaoglu; B Ray
Journal:  Appl Environ Microbiol       Date:  1998-06       Impact factor: 4.792

7.  The pediocin AcH precursor is biologically active.

Authors:  B Ray; R Schamber; K W Miller
Journal:  Appl Environ Microbiol       Date:  1999-06       Impact factor: 4.792

8.  Heterologous expression and purification of active divercin V41, a class IIa bacteriocin encoded by a synthetic gene in Escherichia coli.

Authors:  Christelle Richard; Djamel Drider; Khalil Elmorjani; Didier Marion; Hervé Prévost
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

9.  Novel expression system for large-scale production and purification of recombinant class IIa bacteriocins and its application to piscicolin 126.

Authors:  Gerard M Gibbs; Barrie E Davidson; Alan J Hillier
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

10.  Development of Class IIa Bacteriocins as Therapeutic Agents.

Authors:  Christopher T Lohans; John C Vederas
Journal:  Int J Microbiol       Date:  2011-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.